Saudi Journal of Gastroenterology
Home About us Instructions Submission Subscribe Advertise Contact Login    Print this page  Email this page Small font sizeDefault font sizeIncrease font size 
Users Online: 594 

    Article Cited by others


Concurrent autoimmune hepatitis and grave's disease in Hepatitis C during pegylated Interferon α-2a and ribavirin therapy

Trikudanathan Guru V, Ahmad Imad, Israel Jonathan L

Year : 2011| Volume: 17| Issue : 5 | Page no: 348-352

   This article has been cited by
1 ITM2A Expands Evidence for Genetic and Environmental Interaction in Graves Disease Pathogenesis
Xiao-Ping Ye, Fei-Fei Yuan, Le-Le Zhang, Yu-Ru Ma, Man-Man Zhang, Wei Liu, Feng Sun, Jing Wu, Meng Lu, Li-Qiong Xue, Jing-Yi Shi, Shuang-Xia Zhao, Huai-Dong Song, Jun Liang, Cui-Xia Zheng
The Journal of Clinical Endocrinology & Metabolism. 2017; 102(2): 652
[Pubmed]  [Google Scholar] [DOI]
2 Acute hepatic failure due to autoimmune hepatitis in a patient treated for hepatitis
Gaviria, S.C. and Herrera, Y.P.E. and Sandoval, G.O. and Gutiérrez, J.C.R.
Revista Colombiana de Gastroenterologia. 2013; 28(1): 63-67
[Pubmed]  [Google Scholar]
3 Late autoimmune hepatitis after hepatitis C therapy
Cumali Efe,Alexandra Heurgué-Berlot,Ersan Ozaslan,Tugrul Purnak,Gérard Thiéfin,Halis Simsek,Staffan Wahlin
European Journal of Gastroenterology & Hepatology. 2013; 25(11): 1308
[Pubmed]  [Google Scholar] [DOI]


Read this article